Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Diagnosis to Transplant Interval as a Prognostic Factor in Newly Diagnosed Multiple Myeloma: a 30 Year Single Center Experience. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/ajh.27422
10.1002/ajh.27422 · External reference
of autologous stem cell transplant (ASCT) in multiple myeloma treatment in the lack of novel therapies
10.1182/blood-2025-6365 · 2025 · External reference
Role of Stem Cell Transplantation in Multiple Myeloma
10.3390/cancers13040863 · 2021 · External reference
Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update
10.1038/s41408-022-00645-1 · 2022 · External reference
Unresolved reference
External reference
Stem cell collection from peripheral blood of multiple myeloma patients
10.5306/wjco.v16.i12.103683 · 2025 · External reference
Hematopoietic cell transplants in resource-poor countries: challenges and opportunities
10.1080/17474086.2023.2191946 · 2023 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Multiple Myeloma: Impact of Time to Transplant on the Outcome
10.1016/j.clml.2022.04.020 · 2022 · External reference
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma
10.1002/cncr.26422 · 2012 · External reference
Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
10.1038/s41409-022-01835-y · 2023 · External reference
Unresolved reference
External reference
Unresolved reference
2016 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma
10.1002/cncr.26422 · 2012 · External reference
Unresolved reference
External reference
Multiple Myeloma: Impact of Time to Transplant on the Outcome
10.1016/j.clml · 2022 · External reference
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current Therapies
10.1016/j.clml.2020.05.027 · 2020 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
10.1056/nejmoa2204925 · 2022 · External reference
